Reducing Activities: company scaling back some business operations while continuing others

Stay Scaling Back

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators, patient-specific anti-cancer vaccines, and adjuvants that can be used with a range of vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

Reducing Activities: company scaling back some business operations while continuing others

Stay Scaling Back
Revenue(RF), mln.USD
3
Assets(RF), mln.USD
2
Capital(RF), mln.USD
1
Staff(RF), 2021
78
Taxes(RF), mln.USD
1
Glob.Revenue, mln.USD
156
The Company Statement

Received revenues in Russia in 2021-2024, there is no any official announcement. Revenue decreased in 2024 vs 2023 by more than -20%.

All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner